CERo Therapeutics Holdings, Inc. (NASDAQ: CERO)
$0.0530
-0.0031 ( -8.46% ) 7.8M
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.
Market Data
Open
$0.0530
Previous close
$0.0561
Volume
7.8M
Market cap
$8.12M
Day range
$0.0522 - $0.0593
52 week range
$0.0467 - $12.3800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 16, 2024 |
8-k | 8K-related | 23 | Feb 15, 2024 |
8-k | 8K-related | 16 | Feb 14, 2024 |
8-k | 8K-related | 15 | Feb 12, 2024 |
8-k | 8K-related | 17 | Feb 06, 2024 |
8-k | 8K-related | 16 | Jan 05, 2024 |
def | Proxies and info statements | 3 | Dec 14, 2023 |
8-k | 8K-related | 14 | Dec 11, 2023 |